UNSPSC 85515903: Dilation of left foot artery with drug-eluting intraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to dilation of left foot artery with drug-eluting intraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 047W34Z

UNSPSC 85515903 Dilation of left foot artery with drug-eluting intraluminal device, percutaneous approach is a Commodity code that does not align with recent state and local procurement activity. The code nominally describes a specific interventional vascular procedure, but the recent opportunities posted under it reflect occupational health surveillance, disability medical evaluations, pharmacy benefit management, temporary health professional staffing, surgical carve-out benefits administration, and emergency youth detention medical services — none of which involve arterial dilation or intraluminal devices. This represents a fundamental mismatch between the code's clinical procedure scope and the work state and local agencies are actually purchasing under this designation.

The source contains no relevant recent opportunities aligned with the code's nominal scope of vascular intervention services. The issuing bodies represented — the City of Phoenix Retirement Office, City of Long Beach, Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and Santa Clara County Health System — are acquiring occupational medicine, benefits administration, and clinical staffing services rather than interventional cardiology or vascular surgery procedures. This suggests either systematic tagging error in the source material or that UNSPSC 85515903 is being misapplied in state and local procurement systems. Pursuit under this code is not recommended without independent verification that actual opportunities align with vascular intervention procurement.